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ABSTRACT
This study aimed to assess the intervention effect of cookies and galohgor powder drinks on visceral 
adipose tissue (VAT) and lipid profile in patients with type 2 diabetes mellitus. The study design was quasi 
experimental. Subjects of this study were 26 adults with type 2 diabetes mellitus in Bogor District, West 
Java. Subjects were divided into two intervention groups; cookies and galohgor powder drinks (GCPD) 
group and cookies and powder drinks without galohgor (CPD) group. Both interventions were given for 
38 days period. Analysis of Covariance (ANCOVA) was applied to assess the effect of interventions. 
The average changes in VAT controlled by covariates in GCPD group was significantly higher than in 
CPD group (-33.3% vs +6.7%; p<0.05), while the average changes in blood total cholesterol  in GCPD 
group and CPD group were -8.5% and -3.8% (p>0.05). The average changes of triglycerides level in 
GCPD and with CPD group were -30.9% and +1.6% (p>0.05). The average changes in HDL level for 
GCPD group and CPD group were -9.0% and -12.0% (p>0.05). The average changes in LDL level 
for GCPD group and CPD group were -3.9% and -1.6% (p>0.05). Hence, it can be concluded that the 
administration of cookies and galohgor powder drinks significantly reduced the Visceral Adipose Tissue 
(VAT) in patients with type 2 diabetes mellitus. 
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INTRODUCTION
Type 2 Diabetes mellitus (DM) is defined 
as a chronic metabolic disorder disease due the 
inability of the body to utilize insulin effectively 
so that the blood glucose levels increases (ADA 
2011). DM has grown into a global threat with 
415 million people in the world suffer from DM 
and the number is predicted to increase to 642 
million in 2,040 (IDF 2015). While in Indone-
sia the DM prevalence also increases from only 
1.1% in 2007 to 2.1% in 2013 (Kemenkes 2013).
One of the risk factor for type 2 DM is 
obesity (Omez-Ambrosi et al. 2011). Accumula-
tion of visceral adipose tissue (VAT) in obesity 
increases the risk of insulin resistance (Fatati et 
al. 2009). Insulin resistance is a condition of de-
creased insulin sensitivity which in turn decreases 
insulin metabolic functions (Effendi et al. 2013). 
In addition to impairment in glucose metabolism, 
people with diabetes mellitus are also at risk for 
dyslipidemia, a lipid metabolic disorder charac-
terized by low high-density lipoprotein (HDL) 
cholesterol, elevated triglyceride levels, and 
low-density lipoprotein (LDL) cholesterol (Gadi 
& Samaha 2007). Hence, dyslipidemia is a risk 
factor for cardiovascular and metabolic disease, 
such as atherosclerosis, coronary heart disease 
(CHD), stroke, and metabolic syndrome. Results 
of Riskesdas in 2013 showed that the prevalence 
of high blood cholesterol in Indonesian aged ≥15 
years was 35.9%, high trigliserida was 11.9%, 
high LDL was 15.9%, and low HDL was 22.9% 
(Kemenkes 2013 ).
Polyherbal formulations have long been 
studied as therapeutic agents in DM manage-
ment, one of them is galohgor which made from 
56 types of medicinal plants (Ghorbani 2014; 
Roosita et al. 2006). Galohgor is a traditional 
herb commonly consumed by postpartum mo-
thers in the Sundanese tribe in West Java. It con-
tains various important minerals, such as Fe, Zn, 
Cu, and Mn. In addition, it also contains many 
other functional compounds such as antioxidants, 
alkaloids, triterpenoids and glycosides as well as 
steroids, flavonoids, and saponins (Roosita et al. 
2014). Administration of 0,37 g/kg body weight 
of Galohgor rats decreases the lower levels of 
T3 and T4 and increases the body antioxidant le-
vels (Roosita 2003; Leatemia 2010). It can also 
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lower blood glucose levels, increases serum adi-
ponectin and reserves the liver glycogen level in 
the streptozotocin-induced mice (Firdaus 2016). 
This effect is thought to be caused by the activity 
of various bioactive substances contained in the 
galohgor.
The galohgor is traditionally made by 
roasting and pounding method to produce a coarse 
powder consumed directly (Roosita & Wientarsih 
2013). The crude herbal mixtures are generaly 
difficult to consume in the long term because not 
everyone is accustomed to consume herbs and to 
accept the taste in its original form (Goel & Kaur 
2013). The galohgor cookies and powder drinks 
are made to improve the acceptance and flavor 
of the product so that it can serve as an alterna-
tive choice for functional food products. Cookie 
form is chosen because it is one of the most po-
pular snacks in Indonesia, with average consump-
tion  reaching 0.4 kg/capita/year (Subagjo 2007). 
While powder drink has a longer shelf life than 
any other drink. This study aimed to determine 
the intervention effect of cookies and galohgor 
powder drinks on visceral adipose tissue and lipid 
profile in patients with type 2 diabetes mellitus.
METHODS
Design, location, and time
This study applied quasi experimental de-
sign and was conducted in Bogor for three months 
period, from April 2016 until June 2016.
Sampling
The minimum number of subjects for 
this study was calculated using the approximate 
formula of two independent groups according 
to Lameshow et al. (1997) resulted in the min-
imum of nine subjects for each group. Subjects 
were chosen purposively to meet the inclusion 
criterias which were DM patients with moderate-
ly controlled type 2 diabetes (using diet and one 
type of DM drug), men or menopausal women, 
not currently receiving any insulin therapy, had 
no complications, and willing to join the study by 
signing an informed concent. The exclusion crite-
ria was fasting blood glucose (FBG) level before 
intervention was <126 mg/dl. First screening re-
sulted in 36 patients aged 47-63 years old meet-
ing the inclusion citerias, 16 people in cookies 
and powder drinks without galohgor or the CPD 
group and 10 people in the cookies and powder 
drinks with galohgor or GCPD completed the tri-
al. The ethical approval for the trial was obtained 
from the Research Ethics Committee of the Atma 
Jaya-Catholic University, Indonesia No.422/III/ 
LPPM-PM.10.05/05/2016.
Materials and tools
 The materials for making the Galohgor 
were Tinospora tuberculata (Lamk) Beumee ex 
K. Heyne , Ageratum conyzoides Linn, Plucea in-
dica (L.) Less, Selaginalla plana Hieron, Selag-
inalla wildenowii Backer, hadas, Graptophyllum 
pictum Griff, Melastoma malabathricum L, Psid-
ium guajava Linn, Persea americana Miller, Co-
leus scutellarioides (L.) Benth, Hyptis suaveolus 
(L.) Poi, Paederia foetida L, Chlorantus elatior 
Link, Hyptis brevipes Poit, Strobilanthes crispus 
BL, Goniothalamus macrophyllus (Blume) Hal-
lier f, Lantana camara L, Ficus adelfehli King, 
Desmodium heterophyllum Willd, Hemigraphis 
colorata Hall, Kiremek tulang, Plantago may-
or L, Orthoshipon aristatus (Blume) Miq, Mi-
cromelum pubesenceBlume, Magnolia montana, 
Glochidion arborescen (M.A.) Boerl, Phyllanthus 
urinaria L, Abrus precatorius L, Secamena villo-
sa Blume, Blumea balsamifera (L.) DC, Mikania 
micrantha, Piper betle L, Artemisia vulgaris L, 
Cleredendron serratun (L.) Moon, Nyctanthes 
arbor-tritis, Peperomia pellucida (L.) H.B.K, 
Soncuhus arvensis L, Allium cepa L, Amomun 
cardomomum L, Coriandrum sativum L, Piper 
nigrum L, Myristica fragrans Houtt, Curcuma 
aeruginosa  Roxb, Zingiber officinale Roscoe, 
Kaempferia galangal L, Curcuma domestica 
Vahl, Curcuma xanthorhiza Roxb, Zingiber aro-
maticum Valeton,Psophocarpus tetragonolobus, 
Phaseolus radiatus L, Vigna sinensis, Glycine 
max (L.) Merr, Arachis hypogaea L, Oryza sativa 
var. Glutinosa dan Zaea mays L. These ingredi-
ents were obtained from Sukajadi Bogor Village, 
according to Roosita et al. (2014).
The ingredients for the galohgor cookies 
were extract and galohgor powder, sago flour, 
margarine, powdered sugar, egg yolks, sucralose, 
milk powder, coconut milk, salt, and water. The 
ingredients for the powdered drink were extract 
and galohgor powder, non-dairy creamer, and 
sucralose. The tools for the cookies production 
were mixers, basins, ovens, trays, prints, and 
scales. While, the tools used for powdered drinks 
production were scales, 100 mesh sieves, oven, 
sealer and aluminium foil. 
The blood lipid profile analysis were 
done manually using manual triglycerides re-
agent and manual HDL cholesterol reagent. 
Subjects’ body height was measured using mi-
crotoise with 0.1 cm precision. Bioelectrical 
impedance analysis (BIA) was used to measure 
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the percent of body fat and VAT. The tools for 
drawing the blood sample were 5cc syringe, cot-
ton, alcohol, plaster, tube, and vacutainer. While 
the tool used for lipid profile analysis was a 
yellow selectra with a 500 nm wavelength. 
Procedure
The formulation for the cookies and pow-
der drinks refers to research by Roosita et al. 
(2016). Before the intervention was given, all 
subjects received nutrition education for type 2 
diabetes. The intervention was administered for 
38 days. The subjects in each group were given 
a package of intervention products per day, con-
taining cookies (four pieces of cookies weight as 
much as 24 g) and a pack of powdered drink. The 
powder drink should be brewed with 150 ml of 
warm water before drinking. The cookies given 
for the GCPD group contained 1 g of galohgor 
extract and GCPD group powder drink contain-
ing 1 g of galohgor extract or equal to the total 
of 2 g extract per day. While the cookies and 
powder drink for the CPD group did not contain 
Galohgor. 
Subjects were continuously reminded to 
consume intervention products every other day 
and then measured for their adherence in the first 
week. Any unconsumed cookies or powdered 
drink were returned to the research team. During 
the course of the intervention, any subjects who 
received DM drugs from doctors must continue 
their medication as sugested by the medical pro-
fessionals.
Data collection
Measurement of physical activity was 
done using the Indonesian version of Interna-
tional Physical Activity Questionnaire (IPAQ) 
(Hastuti 2013). VAT was measured by BIA (OM-
RON®). The lipid profiles were analysed from 
the blood serum taken by experts. The nutrient 
intake was obtained from 1×24 hours food recall 
at the beginning of the intervention to establish 
the baseline, while the nutrient intake during the 
intervention period were obtained from 5 x 24 
hours food record. The average nutrient intake 
calculation excluded the intervention products. 
The habit of eating fried food was identified from 
the semi quantitative Food Frequency Question-
naire (SQ FFQ) for the last month done twice at 
the beginning and the end of the intervention.
Data analysis
Data analysis was done with SPSS 16 
program, Nutrisurvey 2007 program download-
ed from www.nutrisurvey.de using Indonesian 
food database and US Department of Agriculture 
(USDA) National Nutrient Database for Standard 
Reference, Release 28 (USDA SR28) availabe 
from www.ars.usda.gov. Independent t-test was 
done to determine differences between groups for 
subject characteristics, nutrition intake, visceral 
adipose tissue (VAT), and lipid profile. Paired 
t-test was applied to test difference of nutrient in-
take before and during intervention. While anal-
ysis of covariance (ANCOVA) was done to de-
termine the effect intervention on VAT and lipid 
profile by controlling covariate or confounding 
variables.
RESULTS AND DISCUSSION
Subject characteristics
The results of the between groups differ-
ence test presented in Table 1 showed that there 
were no significant differences in sex, age and 
physical activity of the subjects. However, there 
was a significant difference in average of BMI 
before intervention in CPD and GCPD groups.
In this study, the majority of the subjects 
were female, this proportion is in line to the data 
of DM prevalence based on doctor's diagnosis 
in Indonesia, where DM is more prevalent in 
women (1.7%) than in men (1.4%) (Kemenkes 
2013). The differences in sex can also affect glu-
cose homeostasis. Men are more at risk of fasting 
blood glucose disorder while women are more at 
risk of impaired glucose tolerance (Mauvais-Jar-
vis 2015). The sex differences can also affect the 
volume of VAT where VAT volume in men is 
higher, however fat accumulation in menopausal 
women tend to also be in the visceral region (Liu 
et al. 2003; Carey et al. 1997). Hence, this study 
involved menopausal subjects to minimise bias 
from the influence of sex on glucose homeostasis 
and VAT distribution.
The average age of the subjects in both 
groups were ≥45 years old. Research results from 
Yuliani et al. (2014) pointed out that elderly DM 
patients aged ≥45 years were more at risk of ex-
periencing CHD complications. Nutrition status 
of subjects from the GCPD based on the BMI 
average belongs to the normal category while the 
CPD group classified as overweight.
Physical activity was assessed based on a 
metabolic equivalent task (MET) score (times/
week). MET is an index to measure the intensity 
of physical activity which is calculated from the 
amount of calories spent per kg body weight per 
hour of all listed activities divided by the equiv-
alent va-lue of hours at rest. One MET is consi- 
dered equal to the energy cost of a sitting person 
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(Hastuti 2013). Physical activity based on total 
MET in CPD and GCPD groups did not differ 
significantly between groups (Table 1). Physical 
activity in type 2 diabetes mellitus can decrease 
metabolic risk factors contributing to the devel-
opment of complications due to diabetes (Qin et 
al. 2010).
Damayati (2017) found that the frequently 
consumed snack by type 2 DM patients was fried 
food. The fried food and the reused oil heated 
repeatedly potentially contains saturated fat and 
trans-fat which it consumed excessively will in-
crease the risk of insulin resistance and artero-
sclerosis (Ilmi et al. 2015; Lovejoy et al. 2002).
 The difference test results before and du-
ring the intervention in Table 2 showed that there 
were no significant change in energy, protein, 
fat, total carbohydrate, fiber, cholesterol, and 
satura- ted fat intake between the two groups. 
However, polyunsaturated fatty acid (PUFA) in-
take of the CPD subjects increased significant-
ly during the course of the intervention but still 
lower than the CPGD subjects. Wang & Hu 
(2017) state that PUFA intake of n-6 and n-3 
are associated with lower CHD risk. Moreover, 
PUFA intake of n-3 has an ability to reduce adi-
pose tissue in obesity through inhibit of pro-
inflammatory cytokine and macrophage migra-
tion into adipose tissue (Tai & Ding 2010). In 
other words, PUFA intake could reduce CHD risk 
and adipose tissue in diabetics.    
Visceral adipose tissue
Before intervention, the Visceral Adipose 
Tissue (VAT) did not differ between groups 
(p=0.50) (Table 3). In this study, administration 
of galohgor in the GCPD group significantly re-
duced VAT compared to the CPD group. Table 
3 showed that the average of VAT changes after 
adjustment of VAT before intervention, sex, ener-
gy and fat intake, except the intervention product, 
and also physical activity during the intervention 
in CPD was +6.7% and in the GCPD group was 
-33.3% compared to VAT prior to intervention. 
Polyherbal mixture has a synergistic effect as an 
antiobesity treatment (Saad et al. 2017). Sternt 
et al. (2013) stated that intervention consist of 
Sphaeranthus indicus and Garcinia mangostana 
mixture for 56 days decreased the waist circum-
ference and hip circumference of obese adult 
subjects. 
VAT is more sensitive to weight loss be-
cause the fat cells (adipocytes) are more sensitive 
to lipolysis. Firdaus (2016) found that galohgor 
Variables CPD GCPD p
Sex2 , n (%)2 0.93
Men 3 (18.8) 2 (20.0)
Women 13 (81.2) 8 (80.0)
Age1 (years) 55.7±4.5 54.6±4.6 0.56
BMI1 (kg/m2) 25.3±3.6 21.2±2.4 0.00*
Physical Activity (Total MET), (times/week) 2
Before intervention, median (min-max) 1,728.8 (276.0 - 9,888.5) 3,072.5(330.0 - 19,908.0) 0.18
During intervention, median (min-max) 1,729.0 (276.0 - 9,889.0) 3,072.5 (231.0 - 19,908.0) 0.20
Table 1.  Subject characteristics based on sex, age, BMI, and physical activity
Variables CPD GCPD
Before During Before During 
Energy (kcal)1 1,507±493a 1,533±432a 1,548±243a 1,555±457a
Protein (g)1 56.0±24.1a 51.0±19.2a 59.5±10.9a 53.8±18.3a
Fat (g)1 62.0±26.7a 62.0±20.9a 61.0±20.0a 67.2±30.0a
Total carbohydrate (g)1 189.7±74.6a 195.8±61.0a 195.9±37.2a 189.3±40.1a
Fiber (g)2 14.1±9.9a 13.2±5.8a 13.6±5.4a 12.5±6.2a
Cholesterol (mg)1 174.0±118.9a 160.4±95.2a 258.5±124.9a 245.8±144.1a
Saturated fats (g)2 13.7±10.0a 17.3±6.4a 22.1±7.0b 18.5±6.7a
PUFA (g)2 8.3±5.7a 12.3±6.7a* 13.3±7.2a 13.7±7.7a 
Frequency of fried food con-
sumption (times/weeks)
6a 6 a 6 a 8 a
Table 2. Nutrients intake and frequency of fried food consumption before and during intervention
1Nutrisurvey; 2USDA; a On the same line, numbers with similar letters show no significant differences between groups (p>0,05) 
(independent t-test); *In the same group there was a real difference before and after the intervention (p<0,05) (paired t-test); 
CPD= powder drinks without galohgor; GCPD= cookies and galohgor powder drinks
x ±SD; 1IIndependent t-test; 2Mann-Whitney test; *p≤0.05; CPD=cookies and powder drinks without galohgor; 
GCPD=cookies and galohgor powder drinks
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increases adiponectin, since the balance of 
energy is influenced by adiponectin it is proposed 
that galohgor may help reduce VAT. Adiponec-
tin influences energy balance through stimula-
tion of free fatty acid oxidation by mitochondria 
via the increase of enzymes expression involved 
in β-oxidation pathways and/or oxidative phos-
phorylation pathways. This chain will increases 
free fatty acid intake into cells, especially muscle 
cells to be utilized as energy sources (Fruebis et 
al. 2001). 
Roosita et al. (2014) found that galohgor 
also contains flavonoids. Flavonoids can act as 
anti-obesity and anti-diabetic (Hosain et al. 2016). 
The effect of flavonoid as anti-obesity is in line 
with Maigoda et al. (2016) who stated that flavo-
noid content plays a role in decreasing the dis-
tribution of fat in the liver measured by reduced 
in VAT weight and liver weight in obese mice 
given powdered red dragon fruit for four weeks. 
The central fat accumulation reduction in the ab-
dominal cavity of the rats happened through sup-
pression of hepatic fatty acid synthesis through 
decreased in the mRNA level of sterol regulato-
ry element binding protein-1c (SREBP-1c) and 
enhancement of fatty acid oxidation enzymes 
through peroxisome proliferator-activated recep-
tors-α (PPAR-α) (Honda et al. 2009)
The average of total cholesterol, trigly- 
ceride, HDL and LDL levels before intervention 
between groups showed no differences (p>0.05) 
(Table 4). At the end of the intervention, it was 
found that the average of total cholesterol levels 
after adjustment for total cholesterol levels be-
fore intervention, BMI, physical activity, fiber 
intake, cholesterol, saturated fat, and fried food 
consumption during intervention in both groups 
were decreasing, with 3.8% decrease in the CPD 
group and 8.5% in the GCPD group (p>0.05) 
compared to the total cholesterol levels before 
intervention. The average of triglyceride levels 
after adjustment for triglyceride levels before 
intervention, BMI, physical activity, fat intake, 
Variables CPD GCPD p
Before 8.9±4.0 a 7.5±6.4 a
After 9.1±3.9 a 5.7±2.6a
Different value of 
adjusted ANCO-
VA
0.6 -2.5 0.02*
Table 3. Visceral adipose tissue average of before 
  and after intervention 
Variables CPD GCPD p
Total cholesterol (mg/dl)
Before 248.6±42.8a 249.4±42.2 a
After 236.1±32.7 a 233.1±51.2 a
Different value of adjusted ANCOVA1 -9.4 -21.2 0.48
Trigliserida (mg/dl)
Before 226.7±100.8 a 188.0±64.0 a
After 208.8±75.1a 164.4±113.7a
Different value of adjusted ANCOVA2 3.6 -58.1 0.06
HDL (mg/dl)
Before 56.5±11.9 a 62.1±10.9 a
After 51.0±10.4 a 54.5±12.8 a
Different value of adjusted ANCOVA3 -6.8 -5.6 0.74
LDL (mg/dl)
Before 146.8±32.2 a 149.9±35.7 a
After 143.3±25.6 a 145.7±46.1 a
Different value of adjusted ANCOVA4 -2.3 -5.9 0.76
Table 4. Average of lipid profile levels before and after intervention
a  On the same line, the numbers with the same letters show no significant differences between the groups (p> 0.05) (independent 
T-test); * Significant with p <0.05 (ANCOVA); 1  Covariates: total cholesterol before intervention, age, BMI before interven-
tion, physical activity during intervention, fiber intake, cholesterol, saturated fat, and frequency of fried foods consumption 
during intervention; 2  Covariates: triglyceride levels prior to intervention, BMI prior to intervention, physical activity, fat 
intake, fiber, and fried foods consumptions during intervention; 3  Covariates: HDL levels before intervention, sex, age, BMI 
before intervention, physical activity, fat intake, protein, fiber, cholesterol, saturated fat, and fried food consumption during 
intervention; 4  Covariates: LDL levels before intervention, age, physical activity, fiber intake, cholesterol, saturated fat and 
PUFA during intervention; CPD=cookies and powder drinks without galohgor; GCPD=cookies and galohgor powder drinks
a  On the same line, the numbers with the same letters show 
no significant differences between the groups (p>0.05) (in-
dependent t-test); * Significant with p<0.05 (ANCOVA); Co-
variates: VAT before intervention, sex, energy intake during 
intervention, intake of fat during intervention, physical ac-
tivity during intervention; CPD=cookies and powder drinks 
without galohgor; GCPD=cookies and galohgor powder 
drinks
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fiber, and fried food consumption during the 
intervention in the GCPD group fell by 30.9% 
compared to the CPD group which rose by 1.6% 
(p>0.05). The average HDL levels after being 
adjusted for HDL levels before intervention, sex, 
age, BMI, physical activity, fat intake, protein, 
fiber, cholesterol, saturated fat, and fried food 
consumption during intervention in both groups 
were decreasing, with 12% decrease in the CPD 
group and 9% in the GCPD group (p>0.05). The 
average LDL levels after being adjusted for LDL 
levels before intervention, age, physical activity, 
fiber intake, cholesterol, saturated fat and PUFA 
intake during the intervention in the GCPD group 
subjects fell by 3.9% and 1.6% in the CPD group 
(p>0.05) (Table 4).
The majority of the research subjects ex-
perienced dyslipidemia indicated by high choles-
terol, triglyceride and LDL levels. Dyslipidemia 
in diabetic patient is resulted from impaired lipo-
protein metabolism and insulin resistance which 
increases fatty acid mobilization from adipose 
tissue. This increases the lipid availability in the 
liver for triglyceride synthesis and for binding 
with apoB to form very low-density lipopro-
tein (VLDL) (Gadi & Samaha 2007). There is a 
significant correlation of dyslipidemia with oc-
currence of CHD in DM patients (Yuliani et al. 
2014). Subjects with dyslipidemia have an in-
creased risks of 6.479 times for CHD compared 
to non-dyslipidemic subjects (95% Cl=2.416- 
17.373) (Farahdika & Azam 2015).
The average HDL levels after being adjust-
ed with covariates; HDL before intervention, sex, 
age, BMI prior to intervention, physical activity, 
fat intake, protein, fiber, cholesterol, saturated 
fat, and fried food consumption during interven-
tion in all groups decreased at the end of the in-
tervention. However, HDL levels in both groups 
were within normal limits. This can be due to the 
limited fiber intake in both groups which was 
still less than the recommended requirement (Ta-
ble 2). Fibers can improve HDL metabolism in 
Asians (Yanai et al. 2014). Intake of saturated 
fats, cholesterol and PUFA were classified as ex-
cessive in both groups. Total intake of saturated 
fat, cholesterol and PUFA in the GCPD subjects 
were more than in the CPD. The intake of satu-
rated fats and excess cholesterol from diet will 
raise cholesterol levels and increase the incidence 
of arterosclerosis. Excess PUFA intake also con-
tributes to arterial plaque (Song et al. 2015). The 
GCPD subjects were more likely to consume 
fried food than the CPD during the course of the 
study. Fried food snacks are generally susceptible 
to recurrent heating and contain saturated fat and 
trans-fats that can increase the risk of insulin re-
sistance and arterosclerosis (Ilmi 2015).
The average changes (adjusted) of to-
tal cholesterol, triglyceride, HDL, and LDL of 
GCPD group subjects showed improvement in li-
pid profiles compared to the subjects in the CPD 
however the differences were not statistically sig-
nificant. This result is in contrast to the results of 
Goel and Kaur (2013) research which found that 
intervention in the form of biscuits containing 
three types of herbs, Trigonella foenum graecum, 
Momordica charantia and Gymnema sylvestre, in 
diabetics for three months significantly improved 
lipid profile. 
In vivo administration of galohgor can in-
crease adiponectin levels, decrease plasma MDA 
levels and increase antioxidant enzyme activity of 
superoxide dismutase (SOD) (Firdaus 2016; Set-
yaningsih et al. 2017). Adiponectin can also in-
crease the efflux of cholesterol from macrophag-
es and suppress the formation of foam cells in 
type 2 DM patients. Activation of adiponectin 
receptor signal (AdipoR) prevents the formation 
of foam cells by inducing cholesterol efflux from 
macrophages through the ATP-binding cassette 
transporter A1 (ABCA1) in macrophages affect-
ed by adiponectin in diabetes (Wang et al. 2013).
CONCLUSION 
Consuming galohgor cookies and drinks 
significantly decrease the visceral adipose tissue 
(VAT) of people with type 2 DM. Intervention 
of cookies and galohgor powder drinks tends to 
lower total cholesterol, triglyceride levels, LDL 
levels, and maintain HDL levels better than the 
control group. However, the differences were 
not statistically significant between the groups. 
Thus, intervention package containing cookies 
and galohgor cookies and powder drinks as much 
as 2 g of Galohgor extract per day for 38 days is 
suggested for type 2 DM patients because it has 
health benefits especially to decrease VAT to help 
prevent DM complications.
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